ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $7,079,000 | +145.8% | 152,795 | +29.3% | 0.32% | +183.8% |
Q1 2019 | $2,880,000 | +65.9% | 118,145 | +14.2% | 0.11% | +109.4% |
Q2 2018 | $1,736,000 | +6.0% | 103,465 | +3.2% | 0.05% | +1.9% |
Q1 2018 | $1,637,000 | -39.7% | 100,300 | -54.6% | 0.05% | -39.5% |
Q3 2017 | $2,717,000 | +14.4% | 220,907 | -22.1% | 0.09% | +34.4% |
Q2 2017 | $2,374,000 | -35.8% | 283,667 | -31.4% | 0.06% | -39.6% |
Q1 2017 | $3,697,000 | -21.1% | 413,530 | -22.4% | 0.11% | -15.2% |
Q4 2016 | $4,685,000 | +42.9% | 533,000 | +9.7% | 0.12% | +37.4% |
Q3 2016 | $3,279,000 | +66.0% | 485,780 | -12.5% | 0.09% | +56.9% |
Q2 2016 | $1,975,000 | +6483.3% | 554,890 | +5345.4% | 0.06% | +5700.0% |
Q1 2016 | $30,000 | -30.2% | 10,190 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $43,000 | -8.5% | 10,190 | -1.8% | 0.00% | 0.0% |
Q3 2015 | $47,000 | -25.4% | 10,380 | -17.5% | 0.00% | -50.0% |
Q4 2013 | $63,000 | -20.3% | 12,575 | -1.8% | 0.00% | 0.0% |
Q3 2013 | $79,000 | – | 12,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |